Aflac Incorporated (AFL)

Market Cap	59.93B
Revenue (ttm)	18.93B
Net Income (ttm)	5.44B
Shares Out	546.59M
EPS (ttm)	9.63
PE Ratio	11.39
Forward PE	16.08
Dividend	$2.32 (2.12%)
Ex-Dividend Date	Feb 19, 2025

Volume	1,141,475
Open	108.14
Previous Close	108.24
Day's Range	107.62 - 109.88
52-Week Range	79.31 - 115.50
Beta	0.93
Analysts	Hold
Price Target	103.43 (-5.67%)
Earnings Date	Apr 30, 2025

About AFL

Aflac Incorporated, through its subsidiaries, engages in the provision of supplemental health and life insurance products. The company operates in two segments: Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The AFLAC U.S. offers accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its p...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,694
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2024, Aflac's revenue was $18.93 billion, an increase of 1.21% compared to the previous year's $18.70 billion. Earnings were $5.44 billion, an increase of 16.83%.

Analyst Forecast

According to 14 analysts, the average rating for AFL stock is "Hold." The 12-month stock price forecast is $103.43, which is a decrease of -5.67% from the latest price.

Price Target

$103.43

(-5.67% downside)

Analyst Consensus: Hold